These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33413293)

  • 21. Evidence for chronic lung impairment in patients treated for pulmonary tuberculosis.
    Vecino M; Pasipanodya JG; Slocum P; Bae S; Munguia G; Miller T; Fernandez M; Drewyer G; Weis SE
    J Infect Public Health; 2011 Nov; 4(5-6):244-52. PubMed ID: 22118719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brief Report: Systemic Inflammation, Immune Activation, and Impaired Lung Function Among People Living With HIV in Rural Uganda.
    North CM; Muyanja D; Kakuhikire B; Tsai AC; Tracy RP; Hunt PW; Kwon DS; Christiani DC; Okello S; Siedner MJ
    J Acquir Immune Defic Syndr; 2018 Aug; 78(5):543-548. PubMed ID: 29683991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.
    Nagu TJ; Aboud S; Mwiru R; Matee MI; Rao M; Fawzi WW; Zumla A; Maeurer MJ; Mugusi F
    Int J Infect Dis; 2017 Mar; 56():39-44. PubMed ID: 28161460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.
    Hosseinipour MC; Bisson GP; Miyahara S; Sun X; Moses A; Riviere C; Kirui FK; Badal-Faesen S; Lagat D; Nyirenda M; Naidoo K; Hakim J; Mugyenyi P; Henostroza G; Leger PD; Lama JR; Mohapi L; Alave J; Mave V; Veloso VG; Pillay S; Kumarasamy N; Bao J; Hogg E; Jones L; Zolopa A; Kumwenda J; Gupta A;
    Lancet; 2016 Mar; 387(10024):1198-209. PubMed ID: 27025337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4⁺ T-cell counts of ≥ 350 cells/μL.
    Nanteza MW; Mayanja-Kizza H; Charlebois E; Srikantiah P; Lin R; Mupere E; Mugyenyi P; Boom WH; Mugerwa RD; Havlir DV; Whalen CC
    J Infect Dis; 2011 Sep; 204(6):884-92. PubMed ID: 21849285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa.
    Komati S; Shaw PA; Stubbs N; Mathibedi MJ; Malan L; Sangweni P; Metcalf JA; Masur H; Hassim S
    AIDS; 2010 Jul; 24(12):1849-55. PubMed ID: 20622529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successfully treated but not fit for purpose: paying attention to chronic lung impairment after TB treatment.
    Harries AD; Ade S; Burney P; Hoa NB; Schluger NW; Castro JL
    Int J Tuberc Lung Dis; 2016 Aug; 20(8):1010-4. PubMed ID: 27393532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung functions among patients with pulmonary tuberculosis in Dar es Salaam - a cross-sectional study.
    Manji M; Shayo G; Mamuya S; Mpembeni R; Jusabani A; Mugusi F
    BMC Pulm Med; 2016 Apr; 16(1):58. PubMed ID: 27107713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial.
    Mfinanga SG; Kirenga BJ; Chanda DM; Mutayoba B; Mthiyane T; Yimer G; Ezechi O; Connolly C; Kapotwe V; Muwonge C; Massaga J; Sinkala E; Kohi W; Lyantumba L; Nyakoojo G; Luwaga H; Doulla B; Mzyece J; Kapata N; Vahedi M; Mwaba P; Egwaga S; Adatu F; Pym A; Joloba M; Rustomjee R; Zumla A; Onyebujoh P
    Lancet Infect Dis; 2014 Jul; 14(7):563-71. PubMed ID: 24810491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study.
    Drain PK; Gounder L; Grobler A; Sahid F; Bassett IV; Moosa MY
    BMJ Open; 2015 Apr; 5(4):e006833. PubMed ID: 25877271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Timing of antiretroviral therapy initiation in adults with HIV-associated tuberculosis: outcomes of therapy in an urban hospital in KwaZulu-Natal.
    Kendon MA; Knight S; Ross A; Giddy J
    S Afr Med J; 2012 Sep; 102(12):931-5. PubMed ID: 23498040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with pulmonary impairment in HIV-infected South African adults.
    Gupte AN; Wong ML; Msandiwa R; Barnes GL; Golub J; Chaisson RE; Hoffmann CJ; Martinson NA
    PLoS One; 2017; 12(9):e0184530. PubMed ID: 28902919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Respiratory symptoms and lung function in patients treated for pulmonary tuberculosis in Malawi: a prospective cohort study.
    Nightingale R; Chinoko B; Lesosky M; Rylance SJ; Mnesa B; Banda NPK; Joekes E; Squire SB; Mortimer K; Meghji J; Rylance J
    Thorax; 2022 Nov; 77(11):1131-1139. PubMed ID: 34937802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies.
    Fenner L; Atkinson A; Boulle A; Fox MP; Prozesky H; Zürcher K; Ballif M; Furrer H; Zwahlen M; Davies MA; Egger M;
    J Int AIDS Soc; 2017 Jun; 20(1):21327. PubMed ID: 28691438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and Tuberculosis.
    Ravimohan S; Maenetje P; Auld SC; Ncube I; Mlotshwa M; Chase W; Tiemessen CT; Vangu MD; Wallis RS; Churchyard G; Weissman D; Kornfeld H; Bisson GP
    Clin Infect Dis; 2020 Aug; 71(4):924-932. PubMed ID: 31751447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced Forced Vital Capacity Among Human Immunodeficiency Virus-Infected Middle-Aged Individuals.
    Verboeket SO; Wit FW; Kirk GD; Drummond MB; van Steenwijk RP; van Zoest RA; Nellen JF; Schim van der Loeff MF; Reiss P;
    J Infect Dis; 2019 Apr; 219(8):1274-1284. PubMed ID: 30418599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between HIV infection and pulmonary function in a rural African population.
    Varkila MRJ; Vos AG; Barth RE; Tempelman HA; Devillé WLJ; Coutinho RA; Grobbee DE; Klipstein-Grobusch K
    PLoS One; 2019; 14(1):e0210573. PubMed ID: 30645622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area.
    Badri M; Ehrlich R; Wood R; Pulerwitz T; Maartens G
    Int J Tuberc Lung Dis; 2001 Mar; 5(3):225-32. PubMed ID: 11326821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of chronic lung impairment in Mozambican TB patients and associated risks.
    Khosa C; Bhatt N; Massango I; Azam K; Saathoff E; Bakuli A; Riess F; Ivanova O; Hoelscher M; Rachow A
    BMC Pulm Med; 2020 May; 20(1):127. PubMed ID: 32381002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial.
    Wallis RS; Ginindza S; Beattie T; Arjun N; Likoti M; Edward VA; Rassool M; Ahmed K; Fielding K; Ahidjo BA; Vangu MDT; Churchyard G
    Lancet Respir Med; 2021 Aug; 9(8):897-908. PubMed ID: 33740465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.